artemisinin has been researched along with Colitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, W; Huai, M; Zeng, J | 1 |
| Chen, Z; Gao, Y; Hu, D; Liang, Q; Ma, Z; Tan, H; Tang, X; Wang, Y; Xiao, C; Xiao, Y; You, Q; Zhang, B; Zhang, X; Zhou, T | 1 |
2 other study(ies) available for artemisinin and Colitis
| Article | Year |
|---|---|
Artemisinin ameliorates intestinal inflammation by skewing macrophages to the M2 phenotype and inhibiting epithelial-mesenchymal transition.
Topics: Animals; Anti-Inflammatory Agents; Artemisinins; Colitis; Colon; Crohn Disease; Cytokines; Dextran Sulfate; Disease Models, Animal; Epithelial-Mesenchymal Transition; Female; Humans; Inflammation Mediators; Macrophages; Mice; Mice, Inbred C57BL; Phenotype; RAW 264.7 Cells; Signal Transduction; Tissue Culture Techniques | 2021 |
Artemisinin protects against dextran sulfate-sodium-induced inflammatory bowel disease, which is associated with activation of the pregnane X receptor.
Topics: Animals; Artemisinins; Cell Line, Tumor; Colitis; Colon; Cytochrome P-450 CYP3A; Dextran Sulfate; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Hep G2 Cells; Humans; Inflammatory Bowel Diseases; Ligands; Male; Mice; NF-kappa B; Pregnane X Receptor; Receptors, Steroid; RNA, Messenger; Signal Transduction; Time Factors | 2014 |